545 related articles for article (PubMed ID: 30532706)
1. Gut Microbiota, Short-Chain Fatty Acids, and Herbal Medicines.
Feng W; Ao H; Peng C
Front Pharmacol; 2018; 9():1354. PubMed ID: 30532706
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbiota, a Potential New Target for Chinese Herbal Medicines in Treating Diabetes Mellitus.
Zhang B; Yue R; Chen Y; Yang M; Huang X; Shui J; Peng Y; Chin J
Evid Based Complement Alternat Med; 2019; 2019():2634898. PubMed ID: 30906411
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota, a new frontier to understand traditional Chinese medicines.
Feng W; Ao H; Peng C; Yan D
Pharmacol Res; 2019 Apr; 142():176-191. PubMed ID: 30818043
[TBL] [Abstract][Full Text] [Related]
4. Scutellariae radix and coptidis rhizoma ameliorate glycolipid metabolism of type 2 diabetic rats by modulating gut microbiota and its metabolites.
Xiao S; Liu C; Chen M; Zou J; Zhang Z; Cui X; Jiang S; Shang E; Qian D; Duan J
Appl Microbiol Biotechnol; 2020 Jan; 104(1):303-317. PubMed ID: 31758238
[TBL] [Abstract][Full Text] [Related]
5. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
6. The interplay between herbal medicines and gut microbiota in metabolic diseases.
Wang L; Gou X; Ding Y; Liu J; Wang Y; Wang Y; Zhang J; Du L; Peng W; Fan G
Front Pharmacol; 2023; 14():1105405. PubMed ID: 37033634
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition: the METS-Microbiome study protocol.
Dugas LR; Lie L; Plange-Rhule J; Bedu-Addo K; Bovet P; Lambert EV; Forrester TE; Luke A; Gilbert JA; Layden BT
BMC Public Health; 2018 Aug; 18(1):978. PubMed ID: 30081857
[TBL] [Abstract][Full Text] [Related]
8. Associations of gut microbiota, dietary intake, and serum short-chain fatty acids with fecal short-chain fatty acids.
Yamamura R; Nakamura K; Kitada N; Aizawa T; Shimizu Y; Nakamura K; Ayabe T; Kimura T; Tamakoshi A
Biosci Microbiota Food Health; 2020; 39(1):11-17. PubMed ID: 32010539
[TBL] [Abstract][Full Text] [Related]
9. Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through Modulating Gut Microbiota.
Lyu M; Wang YF; Fan GW; Wang XY; Xu SY; Zhu Y
Front Microbiol; 2017; 8():2146. PubMed ID: 29167659
[TBL] [Abstract][Full Text] [Related]
10. Gegen Qinlian Decoction Treats Diarrhea in Piglets by Modulating Gut Microbiota and Short-Chain Fatty Acids.
Liu CS; Liang X; Wei XH; Jin Z; Chen FL; Tang QF; Tan XM
Front Microbiol; 2019; 10():825. PubMed ID: 31057525
[TBL] [Abstract][Full Text] [Related]
11. Short Chain Fatty Acids: Essential Weapons of Traditional Medicine in Treating Inflammatory Bowel Disease.
Yao Y; Liu Y; Xu Q; Mao L
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257292
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between traditional Chinese medicine-derived polysaccharides and the gut microbiota: A new perspective to understand traditional Chinese medicine.
Yue B; Zong G; Tao R; Wei Z; Lu Y
Phytother Res; 2022 Nov; 36(11):4125-4138. PubMed ID: 36100366
[TBL] [Abstract][Full Text] [Related]
13. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication.
Silva YP; Bernardi A; Frozza RL
Front Endocrinol (Lausanne); 2020; 11():25. PubMed ID: 32082260
[TBL] [Abstract][Full Text] [Related]
14. Interactions Between Gut Microbiota, Host, and Herbal Medicines: A Review of New Insights Into the Pathogenesis and Treatment of Type 2 Diabetes.
Zheng Y; Gou X; Zhang L; Gao H; Wei Y; Yu X; Pang B; Tian J; Tong X; Li M
Front Cell Infect Microbiol; 2020; 10():360. PubMed ID: 32766169
[TBL] [Abstract][Full Text] [Related]
15. The interaction between the gut Microbiota and herbal medicines.
An X; Bao Q; Di S; Zhao Y; Zhao S; Zhang H; Lian F; Tong X
Biomed Pharmacother; 2019 Oct; 118():109252. PubMed ID: 31545247
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota-derived short chain fatty acids act as mediators of the gut-brain axis targeting age-related neurodegenerative disorders: a narrative review.
Guo B; Zhang J; Zhang W; Chen F; Liu B
Crit Rev Food Sci Nutr; 2023 Oct; ():1-22. PubMed ID: 37897083
[TBL] [Abstract][Full Text] [Related]
17. Short-chain fatty acids: bridges between diet, gut microbiota, and health.
Wang LY; He LH; Xu LJ; Li SB
J Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38780349
[TBL] [Abstract][Full Text] [Related]
18. Integration of Gut Microbiota and Metabolomics for Chinese Medicine Research: Opportunities and Challenges.
Feng WW; Liu J; Cheng H; Peng C
Chin J Integr Med; 2022 Nov; 28(11):1032-1039. PubMed ID: 34755290
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of traditional Chinese medicine in modulating gut microbiota metabolites-mediated lipid metabolism.
Li Y; Ji X; Wu H; Li X; Zhang H; Tang D
J Ethnopharmacol; 2021 Oct; 278():114207. PubMed ID: 34000365
[TBL] [Abstract][Full Text] [Related]
20. The role of short-chain fatty acids in microbiota-gut-brain communication.
Dalile B; Van Oudenhove L; Vervliet B; Verbeke K
Nat Rev Gastroenterol Hepatol; 2019 Aug; 16(8):461-478. PubMed ID: 31123355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
